8A27
EGFR kinase domain in complex with 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-1-oxo-4-(trifluoromethyl)isoindolin-2-yl]-N-thiazol-2-yl-acetamide
Summary for 8A27
Entry DOI | 10.2210/pdb8a27/pdb |
Descriptor | Epidermal growth factor receptor, 1,2-ETHANEDIOL, (2R)-2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-3-oxidanylidene-7-(trifluoromethyl)-1H-isoindol-2-yl]-N-(1,3-thiazol-2-yl)ethanamide, ... (5 entities in total) |
Functional Keywords | kinase inhibitor, transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 38210.05 |
Authors | Kuglstatter, A.,Ehler, A. (deposition date: 2022-06-02, release date: 2022-10-19, Last modification date: 2024-01-31) |
Primary citation | Obst-Sander, U.,Ricci, A.,Kuhn, B.,Friess, T.,Koldewey, P.,Kuglstatter, A.,Hewings, D.,Goergler, A.,Steiner, S.,Rueher, D.,Imhoff, M.P.,Raschetti, N.,Marty, H.P.,Dietzig, A.,Rynn, C.,Ehler, A.,Burger, D.,Kornacker, M.,Schaffland, J.P.,Herting, F.,Pao, W.,Bischoff, J.R.,Martoglio, B.,Alice Nagel, Y.,Jaeschke, G. Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib. J.Med.Chem., 65:13052-13073, 2022 Cited by PubMed: 36178776DOI: 10.1021/acs.jmedchem.2c00893 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.07 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)